The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection.
In the underlying study the diagnostic value of the anaphylatoxin C5a was evaluated in kidney transplantation. In 49 transplant patients the following parameters were measured daily for a mean period of 25.1 days: plasma C5a [P-C5a], urine C5a [U-C5a], serum amyloid A [SAA], serum neopterin [S-NEOP] and urine neopterin [U-NEOP]. Sensitivity, specificity and day of first significant parameter increase (exceeding a cut-off level of > 50%) were evaluated retrospectively during 30 periods of rejection and 30 periods of stable graft function. U-C5a was the parameter with the highest sensitivity (84%) and specificity (84%), increasing in the mean 1.3 days before clinical diagnosis of rejection. Sensitivity and specificity of the other markers was lower: SAA 77% and 77%, U-NEOP 68% and 65%, S-NEOP 45% and 77%, and P-C5a 45% and 48%, respectively. During four instances of cytomegalovirus disease extremely high U-NEOP (> or = 1520 +/- 518 mumol/mol creatinine) and slightly increased P-C5a levels (> or = 1.5 +/- 1.4 ng/ml) occurred. Elevated urinary excretion of C5a seems to be a reliable and early marker of renal allograft rejection. In combination with SAA and U-NEOP, the daily assessment of U-C5a differentiates between viral infection and allograft rejection.
Müller
T F
TF
Department of Nephrology/Centre of Internal Medicine, Philipps-University of Marburg, Germany.
Neumann
C M
CM
Greb
C
C
Kraus
M
M
Lange
H
H
D000328:Adult; D000368:Aged; D001708:Biopterins / Q000031:analogs & derivatives / Q000097:blood; D015936:Complement C5a / Q000032:analysis*; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D012189:Retrospective Studies; D000685:Serum Amyloid A Protein / Q000032:analysis; D014184:Transplantation, Homologous
D000685:Serum Amyloid A Protein; D001708:Biopterins; D019798:Neopterin; D015936:Complement C5a